Log in
Enquire now
‌

US Patent 10278957 Opioid agonist peptides and uses thereof

Patent 10278957 was granted and assigned to Protagonist Therapeutics on May, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Protagonist Therapeutics
Protagonist Therapeutics
0
Current Assignee
Protagonist Therapeutics
Protagonist Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102789570
Patent Inventor Names
Ashok Bhandari0
Larry C. Mattheakis0
Sampath Kumar Anandan0
Brian Troy Frederick0
David Liu0
Gregory Thomas Bourne0
Jie Zhang0
Date of Patent
May 7, 2019
0
Patent Application Number
161283520
Date Filed
September 11, 2018
0
Patent Citations
‌
US Patent 10035824 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 10196424 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 10023614 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 10030061 Hepcidin analogues and uses thereof
0
‌
US Patent 10059744 α4β7 thioether peptide dimer antagonists
0
Patent Citations Received
‌
US Patent 12018057 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
0
‌
US Patent 10729676 Opioid agonist peptides and uses thereof
‌
US Patent 10787490 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
0
‌
US Patent 10941183 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
‌
US Patent 11041000 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
‌
US Patent 11753443 Conjugated hepcidin mimetics
‌
US Patent 11840581 α4β7 thioether peptide dimer antagonists
0
‌
US Patent 11884748 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
0
...
Patent Primary Examiner
‌
Amber D Steele
0
Patent abstract

The invention is directed to opioid agonist peptides and their use.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10278957 Opioid agonist peptides and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.